Search research articles
Contact Us
Filters
Showing results (671-680 of 973) with videos related to
Page
of 98
Sort By:
Blood
|
March 26, 1999
Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency
M Neerman-Arbez, K M Johnson, M A Morris, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer
Nancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
Journal of Lipid Research
|
March 12, 2022
Gut microbiome-derived glycine lipids are diet-dependent modulators of hepatic injury and atherosclerosis
Courtney L Millar, Liya Anto, Chelsea Garcia, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
Development of a Nanoparticle-Based Tendon-Targeting Drug Delivery System to Pharmacologically Modulate Tendon Healing
Emmanuela Adjei-Sowah, Indika Chandrasiri, Baixue Xiao, et al.
Human Gene Therapy
|
August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
Roland W Herzog, Paul A Fields, Valder R Arruda, et al.
Blood
|
May 15, 1993
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A
T C Nichols, D A Bellinger, R L Reddick, et al.
Thoracic Cancer
|
September 19, 2017
Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison
Romaine C Nichols, Soon H Huh, Randal H Henderson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress
T C Nichols, D A Bellinger, R L Reddick, et al.
International Journal of Particle Therapy
|
February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate Cancer
William M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Technology in Cancer Research & Treatment
|
July 7, 2011
Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer
R C Nichols, S H Huh, B S Hoppe, et al.
Page
of 98
Search research articles
Search
Showing results (671-680 of 973) with videos related to
Sort By:
Page
of 98
Blood
|
March 26, 1999
Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency
M Neerman-Arbez, K M Johnson, M A Morris, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 14, 2014
Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer
Nancy P Mendenhall, Bradford S Hoppe, Romaine C Nichols, et al.
Journal of Lipid Research
|
March 12, 2022
Gut microbiome-derived glycine lipids are diet-dependent modulators of hepatic injury and atherosclerosis
Courtney L Millar, Liya Anto, Chelsea Garcia, et al.
Biorxiv : the Preprint Server for Biology
|
December 11, 2023
Development of a Nanoparticle-Based Tendon-Targeting Drug Delivery System to Pharmacologically Modulate Tendon Healing
Emmanuela Adjei-Sowah, Indika Chandrasiri, Baixue Xiao, et al.
Human Gene Therapy
|
August 7, 2002
Influence of vector dose on factor IX-specific T and B cell responses in muscle-directed gene therapy
Roland W Herzog, Paul A Fields, Valder R Arruda, et al.
Blood
|
May 15, 1993
The roles of von Willebrand factor and factor VIII in arterial thrombosis: studies in canine von Willebrand disease and hemophilia A
T C Nichols, D A Bellinger, R L Reddick, et al.
Thoracic Cancer
|
September 19, 2017
Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison
Romaine C Nichols, Soon H Huh, Randal H Henderson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
March 4, 1998
von Willebrand factor does not influence atherogenesis in arteries subjected to altered shear stress
T C Nichols, D A Bellinger, R L Reddick, et al.
International Journal of Particle Therapy
|
February 7, 2022
Insurance Approval for Definitive Proton Therapy for Prostate Cancer
William M Mendenhall, Eric D Brooks, Stephanie Smith, et al.
Technology in Cancer Research & Treatment
|
July 7, 2011
Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer
R C Nichols, S H Huh, B S Hoppe, et al.
Page
of 98